Olema Pharmaceuticals Inc... (OLMA)
NASDAQ: OLMA
· Real-Time Price · USD
5.30
0.14 (2.71%)
At close: May 01, 2025, 3:59 PM
5.52
4.15%
Pre-market: May 02, 2025, 05:32 AM EDT
2.71% (1D)
| Bid | 4.31 |
| Market Cap | 362.31M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -129.47M |
| EPS (ttm) | -2.2 |
| PE Ratio (ttm) | -2.41 |
| Forward PE | -2.08 |
| Analyst | Buy |
| Ask | 5.52 |
| Volume | 623,082 |
| Avg. Volume (20D) | 947,516 |
| Open | 5.13 |
| Previous Close | 5.16 |
| Day's Range | 5.06 - 5.32 |
| 52-Week Range | 2.86 - 16.62 |
| Beta | 2.11 |
About OLMA
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, locally advanced, or metastatic estrogen receptor-positive, human epidermal growth factor receptor 2-negativ...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 19, 2020
Employees 96
Stock Exchange NASDAQ
Ticker Symbol OLMA
Website https://www.olema.com
Analyst Forecast
According to 3 analyst ratings, the average rating for OLMA stock is "Buy." The 12-month stock price forecast is $28, which is an increase of 428.30% from the latest price.
Stock Forecasts5 months ago
+0.89%
Olema Pharmaceutical shares are trading higher aft...
Unlock content with
Pro Subscription
